Refrakter İdiyopatik Multisentrik Castleman Hastalığının Tedavisinde Ruxolitinib: Bir Olgu Sunumu
Yu-han Gao, Ming-hui Duan, Jian Li, Lu ZhangPeking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Beijing, ChinaAnahtar Kelimeler: İdiyopatik multisentrik Castleman hastalığı, Janus kinaz inhibitörü, Ruxolitinib, Tedavi
Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report
Yu-han Gao, Ming-hui Duan, Jian Li, Lu ZhangPeking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Beijing, ChinaKeywords: Idiopathic multicentric Castleman disease, Janus kinase inhibitor, Ruxolitinib, Treatment
Yu-han Gao, Ming-hui Duan, Jian Li, Lu Zhang. Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report. . 2024; 41(1): 61-63
Sorumlu Yazar: Yu-han Gao, China
Sorumlu Yazar: Yu-han Gao, China
| ARAÇLAR |
 Tam Metin PDF Yazdır Alıntıyı İndir RIS EndNote BibTex Medlars Procite Reference Manager E-Postala Paylaş Yazara e-posta gönder
Benzer makaleler Google Scholar |